A globally-renowned prostate cancer surgeon shares the latest advancements in the field and stresses the importance of early ...

Scientists uncover a molecular weakness that could transform prostate cancer therapy. An international team of researchers has identified a new weakness in prostate cancer cells that could enhance ...

A new drug combination cuts the risk of death in people with advanced prostate cancer by 40% over eight years, according to ...

Adding the drug enzalutamide to standard hormone therapy reduced deaths by more than 40% in men with recurrent prostate ...

New ‘gentler’ treatment for prostate cancer gets green light but not all men will have access to it - It comes as concerns ...

Prostate cancer screening could prevent around 1,500 deaths a year in the UK, research suggests. A European trial, one of the ...

The “striking” findings showed an overall upward trend in life expectancy when patients took niraparib - a targeted therapy that blocks cancer cells from repairing their DNA when damaged - alongside ...

Men with prostate cancer that returns after surgery or radiation and are left with few options could benefit from a new ...

Researchers from Australia and China have found two enzymes that help cancer resist treatment. The experiments show that by blocking these could supercharge existing drugs and open the door to new ...

NICE recommendation of darolutamide plus hormone therapy for metastatic prostate cancer offers around 6000 patients in ...

Medical practitioners are constantly updating and refining approaches to prostate cancer care, while new cutting-edge ...

NEW YORK (Reuters Health) - Men diagnosed with localized prostate cancer are more likely to be treated with proton beam therapy, a novel form of radiation therapy, if the technology is available ...